IP Library Granted Patent US 11,225,527
Granted Patent B2
US 11,225,527 · App. 16/513,547 · Granted Jan 18, 2022

Antibodies to paliperidone haptens and use thereof

Inventors: Eric Hryhorenko (Hilton, NY); Banumathi Sankaran (Lexington, MA); Thomas R. DeCory (Pittsford, NY); Theresa Tubbs (Rochester, NY); Linda Colt (Rochester, NY); Maarten Vliegen (Rijkevorsel, BE); Pieter Rik Haspeslagh (Halen, BE)
Assignee: JANSSEN PHARMACEUTICA NV
C07K16/44G01N33/94G01N33/9406C07K2317/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,225,527
App. No.
16/513,547
Granted
Jan 18, 2022
Kind
B2
Abstract

Disclosed is an antibody which binds to paliperidone, which can be used to detect paliperidone in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of paliperidone, including multiplex detection of aripiprazole, olanzapine, quetiapine, risperidone and paliperidone in a single lateral flow assay device.

Claims (20)

1. A conjugate of a compound of Formula I and an immunogenic carrier, Formula I:

wherein

L 1 is OC(O)(CH 2 ) n , or O(CH 2 ) n ;

wherein n is 2 or 3;

L 2 is NHC(O),

or absent; and

L 3 is (CH 2 ) m CO 2 H, or

wherein m is 0, 1, 2, or 3; provided that m may only be 0 if L 2 is absent; and further provided that when L 2 is absent L 3 is

2. The conjugate of claim 1 , wherein the immunogenic carrier is a protein.

3. The conjugate of claim 2 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

4. A conjugate of an immunogenic carrier and a compound selected from the group consisting of:

wherein n is 2 or 3; and m 0, 1, 2 or 3.

5. The conjugate of claim 4 , wherein the compound is

6. The conjugate of claim 4 , wherein the compound is

7. The conjugate of claim 4 , wherein the immunogenic carrier is a protein.

8. The conjugate of claim 7 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

9. A method of preparing a conjugate comprising contacting an immunogenic carrier with a compound selected from the group consisting of:

wherein n is 2 or 3; and m 0, 1, 2 or 3.

10. The method of claim 9 , wherein the immunogenic carrier is a protein.

11. The method of claim 10 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

Continuity (4)
Continuation 15410425 · Jan 19, 2017
Division 13971387 · Aug 20, 2013
Provisional Application 61691634 · Aug 21, 2012
Related Publication 20190338047A1 · Nov 7, 2019